New lung cancer drug shows promise in Mid-Stage trial
NCT ID NCT07019675
First seen Jan 09, 2026 · Last updated May 22, 2026 · Updated 25 times
Summary
This study tests a new drug called SKB518 in 192 people with lung cancer. The goal is to see if it shrinks tumors and is safe. Participants receive the drug until their disease gets worse or side effects become too strong.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Cancer Hospital of Xinjiang Medical University
RECRUITINGÜrümqi, Xinjiang, China
Contact
-
Cancer Hospital Chinese Academy of Medical Science
RECRUITINGBeijing, China
Contact Email: •••••@•••••
-
Cancer Hospital of Guangxi Medical University
RECRUITINGNanning, Guangxi, China
Contact
-
Cancer Hospital of Shandong First Medical University
RECRUITINGJinan, Shandong, China
Contact
-
Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center
RECRUITINGShenzhen, Guangdong, China
Contact
-
Hubei Cancer Hospital
RECRUITINGWuhan, Hubei, China
Contact
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, China
Contact
Contact
-
Jiangxi Cancer Hospital
RECRUITINGNanchang, Jiangxi, China
Contact
-
Renmin Hospital of Wuhan University
RECRUITINGWuhan, Hubei, China
Contact
-
Shanghai Pulmonary Hospital (Affiliated to Tongji University)
RECRUITINGShanghai, China
Contact
-
Shanxi Cancer Hospital
RECRUITINGTaiyuan, Shanxi, China
Contact
-
Taizhou Hospital of Zhejiang Province
RECRUITINGTaizhou, Zhejiang, China
Contact
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, China
Contact
-
Tianjin Medical University Cancer Institute & Hospital
RECRUITINGTianjin, China
Contact
-
Xiangyang Central Hospital
RECRUITINGXiangyang, Hubei, China
Contact
-
Yunnan Cancer Hospital
RECRUITINGKunming, Yunnan, China
Contact
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, Zhejiang, China
Contact
Conditions
Explore the condition pages connected to this study.